| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/18/2014 | WO2014138927A1 Treatment of gluten intolerance and related conditions |
| 09/18/2014 | US20140275618 Therapeutic compounds and methods of use |
| 09/18/2014 | US20140275545 8-carboxamido-2,6-methano-3-benzazocines |
| 09/18/2014 | US20140275115 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 09/18/2014 | US20140271921 Pharmaceutical composition |
| 09/18/2014 | US20140271856 Orally disintegrable tablets |
| 09/18/2014 | US20140271637 Methods of administering anti-tnfalpha antibodies |
| 09/17/2014 | EP2777708A1 Pharmaceutical composition, in particular for the treatment of inflammations of the mucous membrane |
| 09/17/2014 | EP2776427A1 Modulators of atp-binding cassette transporters |
| 09/17/2014 | EP2776048A1 Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
| 09/16/2014 | US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 09/16/2014 | US8835430 2,4-pyrimidinediamine compounds and their uses |
| 09/16/2014 | US8835390 Modulation of osteoclast differentiation |
| 09/16/2014 | US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 09/16/2014 | US8834854 Oral treatment compositions and related methods of manufacture |
| 09/16/2014 | CA2677842C Pharmaceutical composition comprising microparticle oily suspension |
| 09/16/2014 | CA2650970C P38 map kinase inhibitors |
| 09/16/2014 | CA2569856C Prebiotic preparation |
| 09/15/2014 | CA2845336A1 Encapsulated metal ion nanoclusters |
| 09/12/2014 | WO2014138374A1 Oral combination therapy for treating hcv infection in specific patient sub-population |
| 09/12/2014 | WO2014136808A1 Cell-death inhibitor, and production method therefor |
| 09/12/2014 | WO2014136807A1 Cell-death inhibitor, and novel compound |
| 09/12/2014 | WO2014134830A1 Edible composition, food product comprising same, and preparation method for the food product |
| 09/11/2014 | US20140256743 Cathepsin cysteine protease inhibitors |
| 09/11/2014 | US20140256652 Polypeptides Involved In Immune Response |
| 09/11/2014 | US20140255493 Extrudate and methods of using said extrudate |
| 09/10/2014 | EP2774932A1 Novel compound contained in manuka honey and use of same |
| 09/10/2014 | EP2774618A2 Pharmaceutical composition based on epigallocatechin gallate-containing nano-micelles and use thereof to treat atopic dermatitis, crohn's disease, adenomyosis and hyperplastic prostate disorders |
| 09/10/2014 | EP2773369A1 Compositions and methods for preventing and treating oral diseases |
| 09/10/2014 | EP2773348A1 Pharmaceutical composition of omeprazole |
| 09/09/2014 | US8829017 Methods of treating traveler's diarrhea and hepatic encephalopathy |
| 09/09/2014 | US8828973 Compounds as receptor modulators with therapeutic utility |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828947 Polypeptide formulation |
| 09/09/2014 | US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/09/2014 | US8828359 Particulate materials |
| 09/09/2014 | CA2614698C Use of mglur5 (esp. afq056) in gi (esp. gerd) |
| 09/04/2014 | US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells |
| 09/04/2014 | US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 09/03/2014 | EP2772534A1 Technique for isolating/culturing colorectal epithelial stem cell, and technique for transplanting colorectal epithelium employing said technique |
| 09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
| 09/03/2014 | EP2772482A1 Azole derivative |
| 09/03/2014 | EP2772264A1 Application of albizzia chinensis extract in preparation of medicine for treatment of gastric ulcer |
| 09/03/2014 | EP2772250A1 Enteric composition for the manufacture of soft capsule wall |
| 09/03/2014 | EP2771360A1 Immunobinders directed against sclerostin |
| 09/03/2014 | EP2771003A1 Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| 09/03/2014 | EP2770990A1 Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease |
| 09/02/2014 | US8822685 2,4-pyrimidinediamine compounds and their uses |
| 09/02/2014 | US8822637 Somatostatin analogues |
| 09/02/2014 | US8822449 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 09/02/2014 | US8822430 Antiviral compounds |
| 09/02/2014 | US8821866 Methods of treating and preventing colitis involving IL-13 and NK-T cells |
| 08/28/2014 | WO2014130068A1 Methods for increasing oral ostenogenesis using lipoxin a4 (lxa4) and its analogs |
| 08/28/2014 | WO2014128173A1 Gm-csf for treatment of chronic oral mucositis |
| 08/28/2014 | US20140242051 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof |
| 08/28/2014 | US20140242000 Composition, comprising hydrofluoric acid, for inhibiting dental erosion |
| 08/27/2014 | EP2769976A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 08/27/2014 | EP2769717A1 A composition comprising reduced glutathione and acetaminophen and preparation method thereof |
| 08/27/2014 | EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto |
| 08/26/2014 | US8815821 Double-stranded oligonucleotides |
| 08/26/2014 | CA2780821C Mmp-13 inhibitors for the treatment of periodontitsis |
| 08/26/2014 | CA2476755C Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 08/21/2014 | WO2014127066A1 Probiotic arginolytic oral compositions and methods of making and using probiotic arginolytic oral compositions |
| 08/21/2014 | WO2014126921A1 Monoclonal antibodies that neutralize norovirus |
| 08/21/2014 | WO2014125084A1 Hydroxyindalpine derivatives and their medical use |
| 08/21/2014 | WO2014124527A1 Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells |
| 08/21/2014 | WO2013121452A8 Product comprising glucomannan and chitosan for the treatment of gastroesophageal reflux disease |
| 08/21/2014 | US20140235665 Anti-constipation composition |
| 08/21/2014 | US20140234260 Compositions and methods for probiotic recolonization therapies |
| 08/20/2014 | EP2767286A1 Oral pharmaceutical composition for the treatment of inflammatory gastrointestinal diseases |
| 08/20/2014 | EP2767173A1 Use of human milk oligosaccharides in infant nutrition |
| 08/20/2014 | EP2766042A1 ANTIBODIES TO CD1d |
| 08/20/2014 | EP2766027A1 Raising and diagnosing of serotonin level |
| 08/20/2014 | EP2766026A1 Prevention and diagnosis of visceral fat |
| 08/20/2014 | EP2766011A1 Treatment of pharmacological-induced hypochlorhydria |
| 08/19/2014 | US8809542 Salts of benzimidazole compound and use thereof |
| 08/19/2014 | US8809323 Therapeutic applications of pro-apoptotic benzodiazepines |
| 08/19/2014 | US8809265 Methods for treating HCV |
| 08/19/2014 | US8808691 Method for treating tumors and their metastases |
| 08/19/2014 | CA2562473C Preventive and/or therapeutic agent for inflammatory bowel diseases |
| 08/19/2014 | CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use |
| 08/14/2014 | WO2014122660A1 Cd14 inhibitors as an effective treatment for hcv infection |
| 08/14/2014 | WO2014122199A1 Methods and pharmaceutical compositions for treatment of chronic intestinal pseudo-obstruction |
| 08/14/2014 | WO2014121758A1 Human hepatocyte-like cells and uses thereof |
| 08/14/2014 | WO2014121449A1 Preparing tooth-like structure using stem cell |
| 08/14/2014 | WO2014101295A3 Isoxazole derivative that inhibits activity of janus kinases (jaks) |
| 08/14/2014 | WO2014093305A3 Micrornas and uses thereof |
| 08/14/2014 | US20140228431 Method of treating constipation |
| 08/14/2014 | US20140227341 Methods of using regenerative cells to promote wound healing |
| 08/14/2014 | US20140227234 Methods of using regenerative cells to promote wound healing |
| 08/13/2014 | EP2764872A1 Treatment of fructose malabsorption |
| 08/13/2014 | EP2764864A1 Novel anti-hcv agent |
| 08/13/2014 | EP2763692A2 Use of igf-1 in the modulation of treg cell activity and the treatment and prevention of autoimmune disorders or diseases |
| 08/13/2014 | EP2763690A1 Glp-1 agonist for use in the treatment of stenosis or/and obstruction in the pancreatic duct system |
| 08/13/2014 | EP2763685A1 Bacterium for use as a probiotic for nutritional and medical applications |
| 08/13/2014 | EP2763546A1 Gluten-free food composition and food products prepared therefrom |
| 08/13/2014 | EP2650367A9 Human monoclonal antibody |
| 08/13/2014 | CN203763525U 奥美拉唑和碳酸氢钠包芯片 Omeprazole and sodium bicarbonate chip package |
| 08/13/2014 | CN103987706A 吡啶酮衍生物以及含有吡啶酮衍生物的药物 Pyridinone derivatives, and the drug-containing pyridone derivatives |
| 08/13/2014 | CN103987393A 能够恢复在胃酸过多的药物治疗期间丧失的胃本身的屏障效应的包括与益生菌联合的n-乙酰半胱氨酸和/或微胶囊化的胃保护性溶菌酶的组合物 Hyperacidity can restore lost during the drug treatment of gastric barrier effect itself include probiotics combined with n- acetylcysteine and / or microcapsules of gastroprotective lysozyme composition |